PX'Therapeutics Overview

  • Founded
  • 2000
  • Status
  • Acquired/​Merged
  • Employees
  • 29
  • Latest Deal Type
  • M&A

PX'Therapeutics General Information


Operator of a biotechnology company focused on biotherapeutics. The company offers contract research, development and manufacturing services for recombinant proteins and monoclonal antibodies.

Contact Information

Formerly Known As
Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare Services
Other Industries
Aguettant Sante
Primary Office
  • 7, parvis Louis Néel MINATEC - BHT 52 A
  • CS 20050
  • 38040 Grenoble
  • France
+33 04 00 00 00 00
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PX'Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 03-Oct-2012 00.000 Completed Generating Revenue
3. Secondary Transaction - Private 06-Feb-2008 00.000 00.000 Completed Generating Revenue
2. Grant 19-Nov-2003 $1.52M Completed Startup
1. Early Stage VC 19-Nov-2003 $1.52M $1.52M Completed Startup
To view PX'Therapeutics’s complete valuation and funding history, request access »

PX'Therapeutics Executive Team (2)

Name Title Board Seat Contact Info
Tristan Rouselle Chief Executive Officer & Co-Founder
Nicolas Mouz Co-Founder
To view PX'Therapeutics’s complete executive team members history, request access »

PX'Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PX'Therapeutics Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Amorcage Rhone-Alpes Venture Capital Minority 000 0000 000000 0
Crédit Mutuel Equity Growth/Expansion Minority 000 0000 000000 0
Kevin D'Silva Angel (individual) Minority 000 0000 000000 0
Rhône Dauphiné Développement Venture Capital Minority 000 0000 000000 0
Rhône-Alpes Création Venture Capital Minority 000 0000 000000 0
To view PX'Therapeutics’s complete investors history, request access »